See What HealthDay Can Do For You
Contact Us

Clinical Comorbidities Up After Arthroscopic Hip Surgery

Increases seen in mental health disorders, chronic pain, substance use disorders, heart disorders


FRIDAY, Oct. 5, 2018 (HealthDay News) -- Following elective arthroscopic hip surgery, the rate of seven major clinical comorbidities increases significantly, according to a study published online Sept. 27 in the British Journal of Sports Medicine.

Daniel I. Rhon, P.T., from the Brooke Army Medical Center in San Antonio, and colleagues collected data from 1,870 individuals (mean age, 32.24 years) undergoing arthroscopic hip surgery between 2004 and 2013 from the Military Health System Data Repository. Twelve months before and 24 months after surgery, seven comorbidities related to poor outcomes from musculoskeletal disorders were assessed.

The researchers found that after surgery, there were statistically significant increases for all comorbidities, relative to baseline. Cases of mental health disorders, substance use disorders, and sleep disorders increased 84, 57, and 111 percent, respectively, while there were increases of 166 and 71 percent in chronic pain diagnoses and cardiovascular disorders, respectively. Metabolic syndrome cases increased 85.9 percent and systemic arthropathy increased 132 percent.

"Major (potentially 'hidden') clinical comorbidities increased substantially after elective arthroscopic hip surgery when compared with preoperative status," the authors write. "These comorbidities appear to have been overlooked in major studies evaluating the benefits and risks of arthroscopic hip surgery."

Abstract/Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.